Urolithin A has attracted serious scientific attention for its ability to trigger mitophagy: the cellular housekeeping process that identifies and removes worn-out mitochondria so healthier ones can take their place. As consumer interest has grown, two categories of products have emerged: Mitopure, a proprietary standardized form developed by the Swiss company Amazentis, and a widening field of generic urolithin A supplements sold at lower price points. The question of whether the brand difference matters is reasonable and worth examining honestly.
This article walks through what Mitopure is, what clinical research has actually tested, what we know about how urolithin A behaves in the body, and where the evidence leaves genuine gaps. The goal is not to recommend one product over another but to help you understand what the published science does and does not support.
Key Takeaways
- Clinical trials on urolithin A’s effects on muscle strength and immune markers used Mitopure specifically, not generic formulations.
- Urolithin A works by stimulating mitophagy, the cellular process that clears and replaces damaged mitochondria.
- Many people produce little urolithin A from diet alone due to gut microbiome variability, which is the rationale for direct supplementation.
- Generic urolithin A may contain the same molecule but lacks the independent clinical evidence attached to Mitopure.
- If choosing a generic, third-party purity certification provides meaningful quality assurance in the absence of clinical trial data.
What Mitopure Is and Why It Was Developed
Mitopure is a purified, synthetic form of urolithin A manufactured under controlled conditions to ensure consistent dose and purity. It was created because urolithin A produced naturally in the body depends entirely on an individual’s gut microbiome composition. When people eat ellagitannin-rich foods (pomegranates, walnuts, certain berries) gut bacteria convert those polyphenols into urolithin A, but only in people who carry the right bacterial populations. Research has estimated that a significant portion of the population produces little or no urolithin A from diet alone [1].
By delivering urolithin A directly as a supplement rather than relying on microbial conversion, Mitopure bypasses that variability. The clinical trials published to date on urolithin A’s effects on muscle and immune function used Mitopure specifically, which means the evidence base is tied to this standardized form rather than to urolithin A as a molecule in general.
The Clinical Evidence and What It Was Testing
Two randomized controlled trials provide the most direct human evidence for urolithin A supplementation. A 2022 company-funded trial in 88 middle-aged adults missed its primary endpoint (peak power output); on secondary endpoints, hamstring peak torque rose 12% from baseline in one dose group while the placebo group fell 9.8%, and some mitochondrial biomarkers shifted [2]. A more recent 2025 trial published in Nature Aging investigated urolithin A’s effects on age-related immune decline and found small differences in immune cell measures: the share of naive-like CD8+ T cells rose by 0.50 percentage points versus placebo in a 50-person, 4-week trial funded by Amazentis [3].
Research note: Only nine adverse events were recorded over the 28-day immune trial: four in the urolithin A group and five in the placebo group [3].
Both trials were funded by Amazentis SA, the maker of Mitopure. The 2022 middle-aged trial missed its pre-specified primary endpoint, and a 2024 systematic review of five trials (250 people) found no effect on physical function [2][9][3][10].
Critically, both of these trials used Mitopure at defined doses. This is an important limitation to acknowledge: the clinical findings from these studies cannot be automatically extended to generic urolithin A products. A generic supplement might deliver the same molecule, but whether it achieves comparable plasma concentrations, uses the same particle size or formulation, or has undergone any equivalent safety and bioavailability testing is not established by those trials.
How Urolithin A Works: The Mitophagy Mechanism
Mitochondria are the energy-producing structures inside cells. Like any working machinery, they accumulate damage over time. Mitophagy is the selective autophagy pathway that tags dysfunctional mitochondria for degradation, allowing the cell to replace them with newer, more efficient ones. In aging tissues and in sedentary or metabolically stressed individuals, this renewal process slows down, and damaged mitochondria accumulate.
Urolithin A is proposed to activate mitophagy through the PINK1 and Parkin pathway, based mostly on cell, worm and mouse work [6][7]. By stimulating this recycling process, it may support the overall quality of the mitochondrial pool in muscle and immune cells. This mechanism is why researchers have focused on muscle strength and immune function as outcome measures: both are known to decline with age in ways linked to mitochondrial dysfunction [2][3].
It is worth noting that mitophagy activation has a ceiling: the body also needs functional mitochondria to survive, and pharmacokinetic modeling suggests that standard supplemental doses of urolithin A reach concentrations that are orders of magnitude below levels associated with toxicity, while potentially still reaching ranges relevant to biological activity [4].
Bioavailability: Why Formulation Can Matter
Bioavailability refers to how much of a compound actually reaches systemic circulation after ingestion. For urolithin A, physiologically-based pharmacokinetic modeling has been used to predict how the body absorbs and distributes the compound, and this work suggests that bioavailability varies and is considerably lower than concentrations that would cause harm, while still potentially reaching ranges that could produce biological effects [4].
Matching a 500 mg dose from pomegranate juice would take about six glasses a day, on average
Few people have it in blood
Only 12% of 100 healthy American adults had detectable urolithin A glucuronide at baseline, before any pomegranate challenge.
About six glasses
The authors estimate matching a 500 mg supplement from pomegranate juice would take about six glasses (approx. 1.5 L) a day, on average.
At least 6 times higher
A vendor page says a 500 mg Mitopure serving gives at least 6 times higher urolithin A blood levels than 8 ounces of pomegranate juice. This is the seller's claim.
Direct urolithin A reaches blood more reliably than juice, but these facts do not show one brand beats another.
Juice estimate from a trial in 100 healthy US adults. Source: Singh et al., European Journal of Clinical Nutrition 2022; Timeline (Amazentis) 2026.
Embed this chart
Free to reuse on your site. Copy the code below; please keep the credit link.
For any polyphenol-derived compound, particle size, crystalline form, co-formulation with fats or other excipients, and manufacturing process can all influence how much of the active ingredient a person actually absorbs. Mitopure has published data on its bioavailability profile as part of its clinical development program. Generic products typically have not. This does not mean generics are ineffective, but it does mean the consumer is working with less information when choosing one.
Natural sources of ellagitannins (pomegranates, oak-derived extracts, certain berries) also provide precursor compounds that some individuals can convert to urolithin A via gut bacteria [1][5]. However, as noted above, a large portion of people lack the relevant microbiome composition to reliably produce meaningful urolithin A this way, which is the fundamental argument for direct supplementation over dietary precursors.
What Generic Urolithin A Products Offer and Where They Fall Short
Generic urolithin A supplements entered the market as the compound moved off-patent for certain applications and as synthesis methods became accessible to contract manufacturers. They are typically sold at a fraction of the cost of Mitopure, which represents a meaningful practical consideration for consumers supplementing daily over months or years.
The core limitation of generics is not that they necessarily contain a different or inferior molecule, pure urolithin A is urolithin A, but that independent clinical trials testing their specific formulations do not exist in the published literature reviewed here. A buyer choosing a generic cannot point to a randomized controlled trial that used that product and showed a measurable effect. They are effectively extrapolating from Mitopure’s evidence to their chosen product, which is a reasonable inference but not a confirmed one.
Third-party testing for purity and label accuracy is an additional consideration. Certificate of analysis documentation, NSF or USP certification, or equivalent quality verification provides some assurance about what is actually in the capsule. Without such documentation, the buyer has no independent confirmation that the stated dose of urolithin A is present and that contaminants are absent.
Making a Practical Decision
The honest summary is that the published clinical evidence for urolithin A’s effects on muscle health [2] and immune function [3] was generated using Mitopure, and no equivalent body of evidence yet exists for generic formulations. If closely following the researched form and dose matters to you, Mitopure is the product that has been tested.
If cost is a primary constraint, a generic from a manufacturer that provides third-party purity testing is a more reasonable choice than one with no quality documentation. The underlying molecule is the same, and the mechanistic rationale, stimulating mitophagy to support mitochondrial renewal, does not change. What changes is the level of clinical certainty you can attach to the specific product in your hand.
Neither category constitutes a medical treatment. Urolithin A supplementation is a nutritional intervention, and like all such interventions it should be considered within the context of broader lifestyle factors: sleep, exercise, diet quality, and medical care for any underlying conditions.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day: The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10): adds resveratrol and CoQ10, a combination the published urolithin A trials did not test. - ProHealth Longevity Urolithin A
capsules, 500 mg: Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg: Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
The research on urolithin A is promising but still early; most human trials have been relatively short in duration and focused on specific populations, so long-term effects remain less characterized. Anyone with a chronic health condition, compromised immune function, or taking prescription medications should consult a qualified healthcare provider before adding urolithin A supplementation to their routine.
Frequently Asked Questions
Has urolithin A been tested in human clinical trials?
Yes. A randomized trial in 88 middle-aged adults missed its primary endpoint (peak power output), though some secondary strength and biomarker measures favoured urolithin A [2]. A separate 2025 randomized controlled trial found a very small shift in CD8+ T-cell measures, which is a cell-metabolism readout rather than a clinical outcome [3]. Both trials used Mitopure, not generic products.
Why can't everyone just eat more pomegranates to get urolithin A?
Urolithin A is produced when gut bacteria metabolize ellagitannins found in pomegranates and certain other foods. However, research indicates that a substantial portion of people lack the gut microbiome composition needed to produce meaningful amounts of urolithin A from dietary precursors [1]. This microbiome variability is why researchers developed direct supplementation as an alternative.
Is urolithin A safe at supplemental doses?
Pharmacokinetic modeling of urolithin A predicts that concentrations achieved through typical supplementation are orders of magnitude below levels associated with toxicity [4]. The clinical trials conducted have not reported serious adverse events, though individuals with medical conditions or taking medications should consult a physician before starting any new supplement.
What does mitophagy actually do, and why does it matter for aging?
Mitophagy is the selective process by which cells identify damaged or dysfunctional mitochondria and break them down for recycling, allowing healthier mitochondria to take their place. Mitochondrial quality tends to decline with age, and this decline is associated with reduced muscle function and immune competence. Urolithin A is proposed to activate mitophagy pathways in cells and animals; in a mouse liver study its protection persisted when mitophagy was blocked, and the human trials have not shown that mitophagy explains their results [6][8][2][3].
Can I get the benefits of urolithin A from oak extract or berry supplements instead?
Foods and extracts rich in ellagitannins (including pomegranate, certain berries, and French oak wood extract) provide compounds that gut bacteria can convert to urolithin A [1][5]. Whether any individual produces sufficient urolithin A from these sources depends heavily on their gut microbiome. Direct urolithin A supplementation bypasses this conversion step, but dietary ellagitannins may offer their own independent benefits and do not represent a fully equivalent approach.
Is Mitopure worth the higher price compared to generics?
The price premium for Mitopure reflects the company-funded trials run on that formulation, whose primary endpoints were largely missed, and the manufacturing standards involved [2][9]. If having trial-validated evidence tied to the exact product you are taking matters to you, Mitopure is the more defensible choice. Generic urolithin A products may deliver the same molecule at lower cost, but they have not been independently tested in randomized controlled trials to date. This is a decision that depends on individual priorities around evidence certainty and budget.
References
- Yin Y et al. Crosstalk between dietary pomegranate and gut microbiota: evidence of health benefits. Critical reviews in food science and nutrition (2024). PMID 37335106
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
- Denk D et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature aging (2025). PMID 41174221
- Aichinger G et al. Physiologically-Based Pharmacokinetic Modeling of the Postbiotic Supplement Urolithin A Predicts its Bioavailability Is Orders of Magnitude Lower than Concentrations that Induce Toxicity, but also Neuroprotective Effects. Molecular nutrition & food research (2023). PMID 37195009
- Natella F et al. Absorption, metabolism, and effects at transcriptome level of a standardized French oak wood extract, Robuvit, in healthy volunteers: pilot study. Journal of agricultural and food chemistry (2014). PMID 24354337
- Peter M. J. Quinn et al. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathologica Communications (2020). PMID 33168089
- Ryu D et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nature medicine (2016). PMID 27400265
- Gao Z et al. Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2. International journal of biological sciences (2022). PMID 35342347
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
- Kuerec AH et al. Targeting aging with urolithin A in humans: A systematic review. Ageing research reviews (2024). PMID 39002645
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.